CONTENT

Destacados

HIVACAT

2nd Antivirals Congress: From Bench to Bedside

11.11.12 - 13.11.12

11-13 November 2012 | Cambridge, MA, USA

 

The key objectives of this congress are:

 

  • To provide a state-of-the-art report for scientists, health professionals and (non)governmental authorities.
  • To accelerate progress in the development and application of antivirals: small molecules and biologics.
  • To serve as an interface between different interest groups from academia, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals.
  • The Congress will be supported by Antiviral Research, the most comprehensive and pre-eminent journal for those interested in the effective control of virus infections in animals and man as well as in plants or lower organisms.

Senior Researcher at IrsiCaixa Dr. José Esté, leader of the research group in HIV pathogenesis, is part of the Scientific Committee.

 

More information

             Boston Marriott Cambridge

             Two Cambridge Center, 50 Broadway

             Cambridge, Massachusetts 02142 USA

             Transport and accommodation